There are currently 980 clinical trials in Tampa, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including Moffitt Cancer Center, University of South Florida, H. Lee Moffitt Cancer Center and Research Institute and Tampa General Hospital. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board
NCT04343365
Recruiting
This study will evaluate the ability of a multidisciplinary group, the Evolutionary Tumor Board (ETB), to develop therapeutic strategies in patients without curative options.
Gender:
All
Ages:
All
Trial Updated:
02/13/2024
Locations: Moffitt Cancer Center, Tampa, Florida
Conditions: Incurable Disease
Register for Updates
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
NCT05581030
Recruiting
The purpose of the study is to evaluate the safety and tolerability of the study drug, calaspargase pegol, when given with multi-agent chemotherapy.
Gender:
All
Ages:
Between 18 years and 50 years
Trial Updated:
02/12/2024
Locations: Moffitt Cancer Center, Tampa, Florida
Conditions: Acute Lymphoblastic Leukemia
Register for Updates
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
NCT05526989
Recruiting
The purpose of the study is to evaluate the efficacy and safety of the combination of niraparib and dostarlimab in patients participants with advanced relapsed/refractory penile cancer.
Gender:
Male
Ages:
18 years and above
Trial Updated:
02/12/2024
Locations: Moffitt Cancer Center, Tampa, Florida
Conditions: Penile Carcinoma
Register for Updates
FA Clinical Outcome Measures
NCT03090789
Recruiting
This multicenter natural history study aims to expand the network of clinical research centers in FA, and to provide a framework for facilitating therapeutic interventions. In addition, this study will lead to the development of valid yet sensitive clinical measures crucial to outcome assessment of patients with Friedreich's Ataxia. This study will support genetic modifier studies, biomarker studies, and frataxin protein level assessments by building a sample repository.
Gender:
All
Ages:
Between 4 years and 80 years
Trial Updated:
02/12/2024
Locations: USF Ataxia Research Center, Tampa, Florida
Conditions: Friedreich Ataxia, Neuro-Degenerative Disease
Register for Updates
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
NCT05215574
Recruiting
Study of NGM831 as Monotherapy and in Combination with Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
Gender:
All
Ages:
18 years and above
Trial Updated:
02/12/2024
Locations: NGM Clinical Study Site, Tampa, Florida
Conditions: Pancreatic Cancer, Breast Cancer, Gastric Cancer, Non-small Cell Lung Cancer, Cervical Cancer, Endocervical Cancer, Squamous Cell Carcinoma of Head and Neck, Bladder Urothelial Cancer, Colorectal Carcinoma, Esophageal Cancer, Ovarian Cancer, Renal Cell Carcinoma, Prostate Cancer, Melanoma, Mesothelioma, Cholangiocarcinoma
Register for Updates
Enhancing Cancer Survivorship With Pickleball
NCT06048822
Recruiting
The purpose of the study is to evaluate the feasibility and acceptability of a pickleball program for cancer survivors and their family members or friends. The program is designed to increase physical activity, improve wellness, and allow individuals to work together to learn and practice the sport.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/12/2024
Locations: Moffitt Cancer Center, Tampa, Florida
Conditions: Cancer
Register for Updates
The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response
NCT06050395
Recruiting
The purpose of the study is to evaluate the feasibility and acceptability of a remote nutrition coaching and monitoring intervention during the 12-weeks of active chemotherapy for borderline resectable and locally advanced pancreatic cancer participants.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/12/2024
Locations: Moffitt Cancer Center, Tampa, Florida
Conditions: Pancreatic Cancer
Register for Updates
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
NCT06001268
Recruiting
The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are undergoing surgery.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/09/2024
Locations: Moffitt Cancer Center, Tampa, Florida
Conditions: Pancreatic Cancer
Register for Updates
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
NCT05748600
Recruiting
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to evaluate improvements in lung function, asthma control, and quality of life. In addition, the study will further evaluate the safety and tolerability of dexpramipexole in participants with eosinophilic asthma.
Gender:
All
Ages:
Between 12 years and 99 years
Trial Updated:
02/09/2024
Locations: Research Site 40001-004, Tampa, Florida
Conditions: Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack
Register for Updates
LASER Pilot Project
NCT05966636
Recruiting
Veterans who use prosthetic limbs commonly suffer from skin problems such as scars that create discomfort and pain to the point that wearing the prosthesis is no longer tolerable. The Veteran must then discontinue prosthetic use to allow healing prior to wearing the limb again. Current treatments for skin problems include manual scar mobilization and massage, stretching, desensitization techniques, pain medication, prosthetic adjustment, steroid injection, scar excision and others. Most of these... Read More
Gender:
All
Ages:
Between 21 years and 70 years
Trial Updated:
02/09/2024
Locations: James A. Haley Veterans' Hospital, Tampa, FL, Tampa, Florida
Conditions: Acquired Absence of Lower Limb, Scar Condition and Fibrosis of the Skin
Register for Updates
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
NCT05763121
Recruiting
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma with an eosinophilic phenotype and a history of asthma exacerbations.
Gender:
All
Ages:
Between 12 years and 99 years
Trial Updated:
02/09/2024
Locations: Research Site 20001-004, Tampa, Florida
Conditions: Eosinophilic Asthma, Asthma; Eosinophilic, Asthma
Register for Updates
KZR-261 in Subjects With Advanced Solid Malignancies
NCT05047536
Recruiting
A first-in-human, open-label, multicenter, Phase 1 study of KZR-261 designed to assess the safety and tolerability, preliminary anti-tumor activity, and pharmacokinetics (PK) of KZR-261, as well as identify the recommended Phase 2 dose (RP2D). The study comprises a Part 1 (Dose Escalation) and a Part 2 (Dose Expansion) in solid organ tumors (melanoma/uveal melanoma, mesothelioma, colorectal cancer, prostate cancer, and "All-Tumors").
Gender:
All
Ages:
18 years and above
Trial Updated:
02/09/2024
Locations: Moffitt Cancer Center, Tampa, Florida
Conditions: Advanced/Metastatic Solid Tumor
Register for Updates